_id
6919e9053c536f8df2318291
Ticker
HEMO.LSE
Name
Hemogenyx Pharmaceuticals PLC
Exchange
LSE
Address
6 Heddon Street, London, United Kingdom, W1B 4BT
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://hemogenyx.com
Description
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer. The company's lead product candidate is the HG-CT-1 therapy for the treatment of relapsed or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat viral infections derived and for certain cancer and neurological conditions; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and therapies for the improvement of bone marrow and blood stem cell transplant procedures. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Last Close
5680000
Volume
7184
Current Price
647.7984
Change
0.35211267605633806
Last Updated
2025-12-30T11:01:14.183Z
Image
https://logo.clearbit.com/hemogenyx.com
Ipo Date
-
Market Cap
34314336
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
313783
Gross Profit
-313783
Operating Expenses
2264292
Operating Income
-2578075
Interest Expense
119889
Pretax Income
-5006415
Net Income
-5004171
Eps
-1.4152395502384387
Dividends Per Share
-
Shares Outstanding
6041255
Income Tax Expense
-
EBITDA
-4572738
Operating Margin
-
Total Other Income Expense Net
-2428340
Cash
226727
Short Term Investments
-
Receivables
343086
Inventories
-
Total Current Assets
569813
Property Plant Equipment
2192649
Total Assets
3101260
Payables
909279
Short Term Debt
827030
Long Term Debt
-
Total Liabilities
3647671
Equity
-500147
Bs_currency_symbol
GBP
Depreciation
313783
Change In Working Capital
582751
Cash From Operations
-3783209
Capital Expenditures
3921
Cash From Investing
260047
Cash From Financing
1672066
Net Change In Cash
67462
Cf_currency_symbol
-
PE
-
PB
-4579.777591250573
ROE
1000.5400412278791
ROA
-161.35928622559862
FCF
-3787130
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
4.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
313783
Quarters > 0 > income Statement > gross Profit
-313783
Quarters > 0 > income Statement > operating Expenses
2264292
Quarters > 0 > income Statement > operating Income
-2578075
Quarters > 0 > income Statement > interest Expense
119889
Quarters > 0 > income Statement > pretax Income
-5006415
Quarters > 0 > income Statement > net Income
-5004171
Quarters > 0 > income Statement > eps
-1.4152395502384387
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3535918
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4572738
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2428340
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
226727
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
343086
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
569813
Quarters > 0 > balance Sheet > property Plant Equipment
2192649
Quarters > 0 > balance Sheet > total Assets
3101260
Quarters > 0 > balance Sheet > payables
909279
Quarters > 0 > balance Sheet > short Term Debt
827030
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3647671
Quarters > 0 > balance Sheet > equity
-500147
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-5004171
Quarters > 0 > cash Flow > depreciation
313783
Quarters > 0 > cash Flow > change In Working Capital
582751
Quarters > 0 > cash Flow > cash From Operations
-3783209
Quarters > 0 > cash Flow > capital Expenditures
3921
Quarters > 0 > cash Flow > cash From Investing
260047
Quarters > 0 > cash Flow > cash From Financing
1672066
Quarters > 0 > cash Flow > net Change In Cash
67462
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.4152395502384387
Quarters > 0 > ratios > PB
-4579.777591250573
Quarters > 0 > ratios > ROE
1000.5400412278791
Quarters > 0 > ratios > ROA
-161.35928622559862
Quarters > 0 > ratios > FCF
-3787130
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
317600
Quarters > 1 > income Statement > gross Profit
-317600
Quarters > 1 > income Statement > operating Expenses
2368347
Quarters > 1 > income Statement > operating Income
-2685947
Quarters > 1 > income Statement > interest Expense
129762
Quarters > 1 > income Statement > pretax Income
-2809874
Quarters > 1 > income Statement > net Income
-2806349
Quarters > 1 > income Statement > eps
-0.8007752800652868
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3504540
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2362511
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-123927
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
159265
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
7856
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
839048
Quarters > 1 > balance Sheet > property Plant Equipment
2727221
Quarters > 1 > balance Sheet > total Assets
4211560
Quarters > 1 > balance Sheet > payables
683284
Quarters > 1 > balance Sheet > short Term Debt
847346
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3358066
Quarters > 1 > balance Sheet > equity
897514
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-2806349
Quarters > 1 > cash Flow > depreciation
317600
Quarters > 1 > cash Flow > change In Working Capital
569499
Quarters > 1 > cash Flow > cash From Operations
-1783403
Quarters > 1 > cash Flow > capital Expenditures
13287
Quarters > 1 > cash Flow > cash From Investing
-24896
Quarters > 1 > cash Flow > cash From Financing
234835
Quarters > 1 > cash Flow > net Change In Cash
-1483497
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.8007752800652868
Quarters > 1 > ratios > PB
2529.4707433377084
Quarters > 1 > ratios > ROE
-312.6802478847126
Quarters > 1 > ratios > ROA
-66.63442999743563
Quarters > 1 > ratios > FCF
-1796690
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
321685
Quarters > 2 > income Statement > gross Profit
-643370
Quarters > 2 > income Statement > operating Expenses
2369455
Quarters > 2 > income Statement > operating Income
-2691
Quarters > 2 > income Statement > interest Expense
283584
Quarters > 2 > income Statement > pretax Income
-2815
Quarters > 2 > income Statement > net Income
-2812
Quarters > 2 > income Statement > eps
-0.000916781536045946
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3067252
Quarters > 2 > income Statement > income Tax Expense
14556
Quarters > 2 > income Statement > EBITDA
-4704254
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-124
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1642762
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
827867
Quarters > 2 > balance Sheet > inventories
-827867
Quarters > 2 > balance Sheet > total Current Assets
2470629
Quarters > 2 > balance Sheet > property Plant Equipment
3006965
Quarters > 2 > balance Sheet > total Assets
6116262
Quarters > 2 > balance Sheet > payables
308660
Quarters > 2 > balance Sheet > short Term Debt
511208
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3092852
Quarters > 2 > balance Sheet > equity
3063905
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-2812
Quarters > 2 > cash Flow > depreciation
321.69
Quarters > 2 > cash Flow > change In Working Capital
66530
Quarters > 2 > cash Flow > cash From Operations
-2350820
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
17328
Quarters > 2 > cash Flow > cash From Financing
2842618
Quarters > 2 > cash Flow > net Change In Cash
395161
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.000916781536045946
Quarters > 2 > ratios > PB
648.5060528955042
Quarters > 2 > ratios > ROE
-0.09177830252569841
Quarters > 2 > ratios > ROA
-0.04597579371191097
Quarters > 2 > ratios > FCF
-2350824
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1345.57
Quarters > 3 > income Statement > operating Income
-1345.57
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1407.8
Quarters > 3 > income Statement > net Income
-1406.42
Quarters > 3 > income Statement > eps
-0.0000011463199934795013
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1226900000
Quarters > 3 > income Statement > income Tax Expense
-1.39
Quarters > 3 > income Statement > EBITDA
-1287168
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1406456.43
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1642762
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2470629
Quarters > 3 > balance Sheet > property Plant Equipment
3006965
Quarters > 3 > balance Sheet > total Assets
6116262
Quarters > 3 > balance Sheet > payables
308660
Quarters > 3 > balance Sheet > short Term Debt
255604
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3092852
Quarters > 3 > balance Sheet > equity
3063905
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1406.42
Quarters > 3 > cash Flow > depreciation
160.84
Quarters > 3 > cash Flow > change In Working Capital
49.33
Quarters > 3 > cash Flow > cash From Operations
-1175.41
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1421.31
Quarters > 3 > cash Flow > net Change In Cash
197.58
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0000011463199934795013
Quarters > 3 > ratios > PB
259402.25201499395
Quarters > 3 > ratios > ROE
-0.04590285925967026
Quarters > 3 > ratios > ROA
-0.022994763795272342
Quarters > 3 > ratios > FCF
-1175.41
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
639285
Annuals > 0 > income Statement > gross Profit
-639285
Annuals > 0 > income Statement > operating Expenses
5087409
Annuals > 0 > income Statement > operating Income
-5726694
Annuals > 0 > income Statement > interest Expense
271555
Annuals > 0 > income Statement > pretax Income
-5625478
Annuals > 0 > income Statement > net Income
-5619181
Annuals > 0 > income Statement > eps
-1.7020440530182215
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3301431
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-4714635
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
101216
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
159265
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7856
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
839048
Annuals > 0 > balance Sheet > property Plant Equipment
2727221
Annuals > 0 > balance Sheet > total Assets
4211560
Annuals > 0 > balance Sheet > payables
683284
Annuals > 0 > balance Sheet > short Term Debt
847346
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3358066
Annuals > 0 > balance Sheet > equity
897514
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-5619181
Annuals > 0 > cash Flow > depreciation
639285
Annuals > 0 > cash Flow > change In Working Capital
602764
Annuals > 0 > cash Flow > cash From Operations
-4116895
Annuals > 0 > cash Flow > capital Expenditures
13284
Annuals > 0 > cash Flow > cash From Investing
-24896
Annuals > 0 > cash Flow > cash From Financing
3077453
Annuals > 0 > cash Flow > net Change In Cash
-1088336
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-1.7020440530182215
Annuals > 0 > ratios > PB
2052.556838110603
Annuals > 0 > ratios > ROE
-626.0828243347736
Annuals > 0 > ratios > ROA
-133.422793454207
Annuals > 0 > ratios > FCF
-4130179
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
645681
Annuals > 1 > income Statement > gross Profit
-645681
Annuals > 1 > income Statement > operating Expenses
4912867
Annuals > 1 > income Statement > operating Income
-5558548
Annuals > 1 > income Statement > interest Expense
315991
Annuals > 1 > income Statement > pretax Income
-6696493
Annuals > 1 > income Statement > net Income
-6690678
Annuals > 1 > income Statement > eps
-2.3701930076826856
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2822841
Annuals > 1 > income Statement > income Tax Expense
-5816
Annuals > 1 > income Statement > EBITDA
-5734823
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1137945
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1247601
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1074
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2169614
Annuals > 1 > balance Sheet > property Plant Equipment
3312438
Annuals > 1 > balance Sheet > total Assets
6105893
Annuals > 1 > balance Sheet > payables
301707
Annuals > 1 > balance Sheet > short Term Debt
546168
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3324887
Annuals > 1 > balance Sheet > equity
2818729
Annuals > 1 > balance Sheet > currency_symbol
GBX
Annuals > 1 > cash Flow > net Income
-6690678
Annuals > 1 > cash Flow > depreciation
645681
Annuals > 1 > cash Flow > change In Working Capital
-833596
Annuals > 1 > cash Flow > cash From Operations
-6105570
Annuals > 1 > cash Flow > capital Expenditures
117285
Annuals > 1 > cash Flow > cash From Investing
-31940
Annuals > 1 > cash Flow > cash From Financing
4449311
Annuals > 1 > cash Flow > net Change In Cash
-1285157
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-2.3701930076826856
Annuals > 1 > ratios > PB
558.8140179492246
Annuals > 1 > ratios > ROE
-237.36506773088152
Annuals > 1 > ratios > ROA
-109.57738696043313
Annuals > 1 > ratios > FCF
-6222855
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2599762
Annuals > 2 > income Statement > gross Profit
-2599762
Annuals > 2 > income Statement > operating Expenses
2930725
Annuals > 2 > income Statement > operating Income
3997548
Annuals > 2 > income Statement > interest Expense
33
Annuals > 2 > income Statement > pretax Income
-3986982
Annuals > 2 > income Statement > net Income
-3979314
Annuals > 2 > income Statement > eps
-1.624625567441137
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2449373
Annuals > 2 > income Statement > income Tax Expense
361158
Annuals > 2 > income Statement > EBITDA
-3422876
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1543505
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2532758
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
9810
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2594782
Annuals > 2 > balance Sheet > property Plant Equipment
3915513
Annuals > 2 > balance Sheet > total Assets
7092609
Annuals > 2 > balance Sheet > payables
374342
Annuals > 2 > balance Sheet > short Term Debt
644314
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
3849089
Annuals > 2 > balance Sheet > equity
3275428
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-3986982
Annuals > 2 > cash Flow > depreciation
195246
Annuals > 2 > cash Flow > change In Working Capital
242590
Annuals > 2 > cash Flow > cash From Operations
-2910604
Annuals > 2 > cash Flow > capital Expenditures
428945
Annuals > 2 > cash Flow > cash From Investing
-420254
Annuals > 2 > cash Flow > cash From Financing
-110144
Annuals > 2 > cash Flow > net Change In Cash
-4308211
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-1.624625567441137
Annuals > 2 > ratios > PB
417.27375292633513
Annuals > 2 > ratios > ROE
-121.48989383982796
Annuals > 2 > ratios > ROA
-56.10508065508757
Annuals > 2 > ratios > FCF
-3339549
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
283647
Annuals > 3 > income Statement > gross Profit
-283647
Annuals > 3 > income Statement > operating Expenses
2702754
Annuals > 3 > income Statement > operating Income
-2702754
Annuals > 3 > income Statement > interest Expense
2595389
Annuals > 3 > income Statement > pretax Income
-5108310
Annuals > 3 > income Statement > net Income
-5099228
Annuals > 3 > income Statement > eps
-2.635423385429587
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1934880
Annuals > 3 > income Statement > income Tax Expense
2414432
Annuals > 3 > income Statement > EBITDA
-2386584
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-2405556
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
6840969
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
7513
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
7139189
Annuals > 3 > balance Sheet > property Plant Equipment
797129
Annuals > 3 > balance Sheet > total Assets
8520410
Annuals > 3 > balance Sheet > payables
295829
Annuals > 3 > balance Sheet > short Term Debt
20304
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
352841
Annuals > 3 > balance Sheet > equity
8191809
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-5108310
Annuals > 3 > cash Flow > depreciation
126340
Annuals > 3 > cash Flow > change In Working Capital
101387
Annuals > 3 > cash Flow > cash From Operations
-2627298
Annuals > 3 > cash Flow > capital Expenditures
817998
Annuals > 3 > cash Flow > cash From Investing
-938953
Annuals > 3 > cash Flow > cash From Financing
8777640
Annuals > 3 > cash Flow > net Change In Cash
5028670
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-2.635423385429587
Annuals > 3 > ratios > PB
131.7978776116484
Annuals > 3 > ratios > ROE
-62.24788688310482
Annuals > 3 > ratios > ROA
-59.847213925151486
Annuals > 3 > ratios > FCF
-3445296
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-1.4152395502384387
Valuation > metrics > PB
-4579.777591250573
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
1000.5400412278791
Profitability > metrics > ROA
-878.2128522866274
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-21.503849394022804
Risk > final Score
-56
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.32817488131432826
Liquidity > metrics > Quick Ratio
0.32817488131432826
Liquidity > final Score
26
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-77
Prev Risks > 1
30
Prev Risks > 2
30
Prev Liquidities > 0
37
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:45.888Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-27
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-25
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.42
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-25
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.79
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.79
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-09-27
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.92
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.92
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-03-31
Earnings History > 4 > report Date
2023-04-28
Earnings History > 4 > date
2023-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBX
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-09-29
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBX
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-04-29
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBX
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-09-30
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBX
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-04-30
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBX
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-06-30
Earnings History > 9 > report Date
2020-09-30
Earnings History > 9 > date
2020-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBX
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-03-31
Earnings History > 10 > report Date
2020-04-30
Earnings History > 10 > date
2020-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBX
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-06-30
Earnings History > 11 > report Date
2019-09-30
Earnings History > 11 > date
2019-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBX
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-03-31
Earnings History > 12 > report Date
2019-04-29
Earnings History > 12 > date
2019-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBX
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-06-30
Earnings History > 13 > report Date
2018-09-28
Earnings History > 13 > date
2018-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBX
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-03-31
Earnings History > 14 > report Date
2018-06-05
Earnings History > 14 > date
2018-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBX
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-06-30
Earnings History > 15 > report Date
2017-09-25
Earnings History > 15 > date
2017-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBX
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-12-31
Earnings History > 16 > report Date
2017-02-03
Earnings History > 16 > date
2016-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBX
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-06-30
Earnings History > 17 > report Date
2016-08-05
Earnings History > 17 > date
2016-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBX
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-03-31
Earnings History > 18 > report Date
2016-05-09
Earnings History > 18 > date
2016-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBX
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer. The company's lead product candidate is the HG-CT-1 therapy for the treatment of relapsed or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat viral infections derived and for certain cancer and neurological conditions; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and therapies for the improvement of bone marrow and blood stem cell transplant procedures. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALondon biotech lines up Jan. 6 listing for fresh batch of shares Stock Titan
Read more →Biotech Hemogenyx adds new shares, reshaping who holds voting power Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Hemogenyx Pharmaceuticals PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-1.42
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.